Serotype 1 Viruses Modified by Backpassage or Insertional Mutagenesis: Approaching the Threshold of Vaccine Efficacy in Marek's Disease

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Avian diseases

• Publication date

  2004-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1637/7203-050304RPMID 15666858
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Biocharacteristics shared by highly protective vaccines against Marek's disease

  2004cited by this paper
• Analyzing the H19- and T65-epitopes in 38 kd phosphorylated protein of Marek's disease viruses and comparing chicken immunological reactions to viruses point-mutated in the epitopes.

  2004cited by this paper
• Field evaluations of safety and efficacy of an Australian Marek's disease vaccine.

  2003cited by this paper
• Derivation, safety and efficacy of a Marek's disease vaccine developed from an Australian isolate of very virulent Marek's disease virus.

  2002cited by this paper
• Induction of Strong Protection by Vaccination with Partially Attenuated Serotype 1 Marek's Disease Viruses

  2002cited by this paper
• Protective efficacy of Marek's disease vaccines.

  2001cited by this paper
• Differential attenuation of the induction by Marek's disease virus of transient paralysis and persistent neurological disease: A model for pathogenesis studies

  2001cited by this paper
• Chicken industry strategies for control of tumor virus infections.

  1998cited by this paper
• Retroviral insertional mutagenesis of a herpesvirus: a Marek's disease virus mutant attenuated for oncogenicity but not for immunosuppression or in vivo replication.

  1997cited by this paper
• Increased virulence of Marek's disease virus field isolates.

  1997cited by this paper
• Retroviral insertional activation in a herpesvirus: transcriptional activation of US genes by an integrated long terminal repeat in a Marek's disease virus clone

  1996cited by this paper
• Characteristics of CVI988/Rispens and R2/23, two prototype vaccine strains of serotype 1 Marek's disease virus.

  1995cited by this paper
• Retrovirus insertion into herpesvirus in vitro and in vivo.

  1992cited by this paper
• Attenuated revertant serotype 1 Marek's disease viruses: safety and protective efficacy.

  1991cited by this paper
• Biological characteristics of Marek's disease vaccine CVI-988 clone C1.

  1987cited by this paper
• New serotype 2 and attenuated serotype 1 Marek's disease vaccine viruses: comparative efficacy.

  1987cited by this paper
• Monoclonal antibodies with specificity for three different serotypes of Marek's disease viruses in chickens.

  1983cited by this paper
• Characteristics of Marek's disease viruses isolated from vaccinated commercial chicken flocks: association of viral pathotype with lymphoma frequency.

  1983cited by this paper
• Protection by attenuated and polyvalent vaccines against highly virulent strains of Marek's disease virus.

  1982cited by this paper
• Characterisation of two highly oncogenic strains of Marek's disease virus.

  1982cited by this paper
• Pathogenicity of variant Marek's disease virus isolants in vaccinated and unvaccinated chickens.

  1980cited by this paper
• An Improved t Table for Simultaneous Control on g Contrasts

  1977cited by this paper
• Characteristics of JMV Marek's disease tumor: a nonproductively infected transplantable cell lacking in rescuable Virus.

  1976cited by this paper
• Effect of passively transferred immunoglobulins on Marek's disease

  1973cited by this paper
• Effect of passively transfered immunoglobulins on Marek's disease.

  1973cited by this paper
• Attenuated Marek's disease herpesvirus: protection conferred on strains of chickens varying in genetic resistance.

  1972cited by this paper
• [Experiment on vaccination against Marek's disease (MD) with a Danish live attenuated MD-virus (CPRL II HP)].

  1972cited by this paper
• Vaccination against Marek's disease with cell-free turkey herpesvirus: interference by maternal antibody.

  1972cited by this paper
• Control of Marek's disease in the Netherlands. I. Isolation of an avirulent Marek's disease virus (strain CVI 988) and its use in laboratory vaccination trials.

  1972cited by this paper
• [Experiment on vaccination against Marek's disease (MD) with a Danish live attenuated MD-virus (CPRL II HP)].

  1972cited by this paper
• Attenuation of Marek's disease virus and study of its properties in two different cell cultures.

  1970cited by this paper
• Immunofluorescence in the study of Marek's disease: detection of antibody.

  1970cited by this paper
• Attenuation of the pathogenicity of Marek's disease virus.

  1970cited by this paper
• Isolation from turkeys of a cell-associated herpesvirus antigenically related to Marek's disease virus.

  1970cited by this paper
• Protection against Marek's disease by vaccination with a herpesvirus of turkeys.

  1970cited by this paper
• Immunization against Marek's Disease using a Live Attenuated Virus

  1969cited by this paper
• The attenuation, with loss of oncogenicity, of the herpes-type virus of Marek's disease (strain HPRS-16) on passage in cell culture.

  1969cited by this paper
• Principles and procedures of statistics.

  1961cited by this paper

• Protection Conferred by Gallid Alphaherpesvirus 2 Vaccines Against Immunosuppression Induced by Very Virulent Plus (vv+) Marek’s Disease Virus Strains in Commercial Meat Type Chickens

  2025cites this paper
• Exophthalmos and Buphthalmos in Broiler Breeders Associated with Marek's Disease Virus.

  2025cites this paper
• Optimizing protocols for monitoring in vivo replication of a novel chimeric Marek’s disease vaccine with an insertion of the long terminal repeat of reticuloendotheliosis virus in the CVI988 strain genome (CVI-LTR)

  2024cites this paper
• Temporal Changes in Splenic Immune Cell Populations following Infection with a Very Virulent plus MDV in Commercial Meat-Type Chickens

  2024cites this paper
• Onset and long-term duration of immunity provided by a single vaccination with recombinant a Marek’s disease virus with REV-LTR insertion

  2024cites this paper
• Poultry Vaccine Technology Platforms.

  2023cites this paper
• Role of T Cells in Vaccine-Mediated Immunity against Marek’s Disease

  2023cites this paper
• Differences in Pathogenicity and Vaccine Resistance Discovered between Two Epidemic Strains of Marek’s Disease Virus in China

  2023cites this paper
• Phenotypic Characterization of Recombinant Marek’s Disease Virus in Live Birds Validates Polymorphisms Associated with Virulence

  2023cites this paper
• Fully Attenuated meq and pp38 Double Gene Deletion Mutant Virus Confers Superior Immunological Protection against Highly Virulent Marek’s Disease Virus Infection

  2022cites this paper
• Characterization of Md5-BAC-REV-LTR virus as Marek’s disease vaccine in commercial meat-type chickens: protection and immunosuppression

  2021cites this paper
• An Anti-Tumor Vaccine Against Marek's Disease Virus Induces Differential Activation and Memory Response of γδ T Cells and CD8 T Cells in Chickens

  2021cites this paper
• A Novel Effective and Safe Vaccine for Prevention of Marek’s Disease Caused by Infection with a Very Virulent Plus (vv+) Marek’s Disease Virus

  2021cites this paper
• B cells do not play a role in vaccine-mediated immunity against Marek’s disease

  2021cites this paper
• Marek’s disease: time to review the emerging threat in Indian poultry

  2020influential citation
• COMPARISON OF CVI AND HVT VACCINE STRAINS REPLICATION IN FEATHER TIPS IN DIFFERENT MAREK´S DISEASE VACCINATION PROGRAMS

  2020cites this paper
• The Emergence of a vv + MDV Can Break through the Protections Provided by the Current Vaccines

  2020influential citation
• Attenuation of a recombinant Marek's disease virus lacking the meq oncogene and evaluation on its immune efficacy against Marek's disease virus

  2020cites this paper
• Revisiting cellular immune response to oncogenic Marek’s disease virus: the rising of avian T-cell immunity

  2020cites this paper
• RNA-seq analysis of viral gene expression in the skin of Marek's disease virus infected chickens.

  2019cites this paper
• Marek’s Disease Virus

  2019cites this paper
• Suspension culture of Marek’s disease virus and evaluation of its immunological effects

  2019cites this paper
• Highly virulent Marek’s disease virus strains affect T lymphocyte function and viability of splenocytes in commercial meat-type chickens

  2019cites this paper
• Lorf9 deletion significantly eliminated lymphoid organ atrophy induced by meq-deleted very virulent Marek's disease virus.

  2019cites this paper
• Study of Efficacy and Replication of Recombinant Vector Vaccines by Using Turkey Herpesvirus Combined with Other Marek's Disease Vaccines

  2019cites this paper
• Identification of Marek's disease virus genes associated with virulence of US strains.

  2019cites this paper
• Co-Infection with Marek’s Disease Virus and Reticuloendotheliosis Virus Increases Illness Severity and Reduces Marek’s Disease Vaccine Efficacy

  2017cites this paper
• Evaluation and Identification of Marek's Disease Virus BAC Clones as Standardized Reagents for Research

  2017cites this paper
• Marek's disease vaccines: Current status, and strategies for improvement and development of vector vaccines.

  2017cites this paper
• Recombinant Gallid herpesvirus 2 with interrupted meq genes confers safe and efficacious protection against virulent field strains.

  2017cites this paper
• History of the First-Generation Marek's Disease Vaccines: The Science and Little-Known Facts

  2016cites this paper
• IMMUNOLOGY, HEALTH, AND DISEASE Deletion of the BAC sequences from recombinant meq-null Marek’s disease (MD) virus increases immunosuppression while maintaining protective efficacy against MD protective efficacy

  2016cites this paper
• Deletion of the BAC sequences from recombinant meq-null Marek's disease (MD) virus increases immunosuppression while maintaining protective efficacy against MD.

  2016cites this paper
• Protection of chickens against very virulent Marek's disease virus (MDV) by an infectious clone of Meq-null MDV vaccination.

  2016cites this paper
• Molecular and pathogenicity characterization of Gallid herpesvirus 2 newly isolated in China from 2009 to 2013

  2016cites this paper
• Protective efficacy of a recombinant bacterial artificial chromosome clone of a very virulent Marek’s disease virus containing a reticuloendotheliosis virus long terminal repeat

  2016cites this paper
• Evaluation of Factors Influencing Efficacy of Vaccine Strain CVI988 Against Marek’s Disease in Meat-Type Chickens

  2015influential citation
• A recombinant field strain of Marek's disease (MD) virus with reticuloendotheliosis virus long terminal repeat insert lacking the meq gene as a vaccine against MD.

  2015cites this paper
• Innate patterning of the immune response to Marek's disease virus (MDV) during pathogenesis and vaccination

  2015influential citation
• Addition of a UL5 helicase-primase subunit point mutation eliminates bursal–thymic atrophy of Marek's disease virus ∆Meq recombinant virus but reduces vaccinal protection

  2015cites this paper
• In vitro model for lytic replication, latency, and transformation of an oncogenic alphaherpesvirus

  2015influential citation
• Evaluation of the Protection Efficacy of a Serotype 1 Marek's Disease Virus-Vectored Bivalent Vaccine Against Infectious Laryngotracheitis and Marek's Disease

  2015cites this paper
• Correlation Between Marek's Disease Virus Pathotype and Replication

  2014influential citation
• Vaccine and oncogenic strains of gallid herpesvirus 2 contain specific subtype variations in the 5′ region of the latency-associated transcript that evolve in vitro and in vivo

  2014cites this paper
• Identifying the genetic basis of attenuation in Marek's disease virus via experimental evolution

  2014cites this paper
• Detection and Differentiation of CVI988 (Rispens Vaccine) from Other Serotype 1 Marek's Disease Viruses

  2014cites this paper
• Differentiation between pathogenic serotype 1 isolates of Marek's disease virus and the Rispens CVI988 vaccine in Australia using real-time PCR and high resolution melt curve analysis.

  2013cites this paper
• Application of a New Bivalent Marek's Disease Vaccine Does Not Interfere with Infectious Bronchitis or Newcastle Disease Vaccinations and Proves Efficacious

  2013cites this paper
• Properties of a meq-Deleted rMd5 Marek's Disease Vaccine: Protection Against Virulent MDV Challenge and Induction of Lymphoid Organ Atrophy Are Simultaneously Attenuated by Serial Passage In Vitro

  2013cites this paper
• Cloning of a Very Virulent Plus, 686 Strain of Marek's Disease Virus as a Bacterial Artificial Chromosome

  2013cites this paper
• Cell culture attenuation eliminates rMd5ΔMeq-induced bursal and thymic atrophy and renders the mutant virus as an effective and safe vaccine against Marek's disease.

  2012cites this paper
• Dynamic equilibrium of Marek’s disease genomes during in vitro serial passage

  2012cites this paper
• Standardization of a model to study revaccination against Marek's disease under laboratory conditions

  2012influential citation
• Optimization of the Protocols for Double Vaccination Against Marek's Disease by Using Commercially Available Vaccines: Evaluation of Protection, Vaccine Replication, and Activation of T Cells

  2012cites this paper
• Development of novel virus vectors for influenza vaccination

  2012influential citation
• Evaluation of Factors Affecting Vaccine Efficacy of Recombinant Marek's Disease Virus Lacking the Meq Oncogene in Chickens

  2011influential citation
• Enhancement of Protective Immune Responses in Chickens against Marek’s Disease Virus

  2011cites this paper
• Replication ability of three highly protective Marek's disease vaccines: implications in lymphoid organ atrophy and protection

  2011cites this paper
• Herpesvirus Telomerase RNA (vTR) with a Mutated Template Sequence Abrogates Herpesvirus-Induced Lymphomagenesis

  2011cites this paper
• Chronological study of cytokine transcription in the spleen and lung of chickens after vaccination with serotype 1 Marek's disease vaccines.

  2011cites this paper
• Effect of Diluting Marek's Disease Vaccines on the Outcomes of Marek's Disease Virus Infection When Challenged with Highly Virulent Marek's Disease Viruses

  2011cites this paper
• Comparative evaluation of vaccine efficacy of recombinant Marek's disease virus vaccine lacking Meq oncogene in commercial chickens.

  2010cites this paper
• Evaluation of factors influencing replication of serotype 1 Marek's disease vaccines in the chicken lung

  2010influential citation
• Immune responses against Marek's disease virus

  2010cites this paper
• Accumulation of attenuating mutations in varying proportions within a high passage very virulent plus strain of Gallid herpesvirus type 2.

  2010cites this paper
• Factors Influencing The Attenuation of Serotype 1 Marek's Disease Virus by Serial Cell Culture Passage and Evaluation of Attenuated Strains for Protection and Replication

  2009cites this paper
• Recombinant Marek's disease virus (MDV) lacking the Meq oncogene confers protection against challenge with a very virulent plus strain of MDV.

  2008cites this paper
• Marek's disease vaccines: a solution for today but a worry for tomorrow?

  2008cites this paper
• Load of Challenge Marek's Disease Virus DNA in Blood as a Criterion for Early Diagnosis of Marek's Disease Tumors

  2008cites this paper
• Integrating Genomics to Understand the Marek’s Disease Virus – Chicken Host–Pathogen Interaction

  2008cites this paper
• Marek's Disease Virus-Induced Skin Leukosis in Scaleless Chickens: Tumor Development in the Absence of Feather Follicles

  2007cites this paper
• Correlation of Marek's disease herpesvirus vaccine virus genome load in feather tips with protection, using an experimental challenge model

  2007cites this paper
• Evaluation of Marek's disease field isolates by the “best fit” pathotyping assay

  2007cites this paper
• Animal vaccination and the evolution of viral pathogens.

  2007cites this paper
• Marek's disease virus: from miasma to model

  2006cites this paper
• Marek's disease: the continuing struggle between pathogen and host.

  2005cites this paper